Boston, MA · Founded 2014 · Privately Held (backing)
Operator of an ophthalmic biologics and device company intended for the treatment of presbyopia, hyperopia and myopia. Allotex is based in Boston, MA and was founded in 2014. It was valued at $358 million at its early-stage round in Mar 2018, the last priced event on record. It has raised $46.8 million across 1 recorded round; the latest was a $16.7 million early-stage round in Feb 2018.
PMV mark · valuation
$358.0M
Oct 2026
Priced at
its early-stage round
Mar 2018
Total raised
$46.8M
Last round
Early Stage VC
Feb 2018
Cap table — not yet on record
Allotex's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Allotex with a free account
·Watch Allotex: the Monday email on marks, rounds and moves